Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: esxtarus who wrote (1930)	4/9/1998 5:21:00 PM
From: Jim Gary	Read Replies (3) \| Respond to of 8117

esxtarus: Did your source identify the New York firms? I would like to find a little more information. I am a US investor long this little gem for nearly a couple of years. Looking forward to some good things. I have considerable trouble finding interest or even quotes in US. I get Canadian quotes, but my shares have a symbol of PYNGF and are quoted in US dollars rather than PYT.V which is quoted in Canadian dollars. I hate doing the monetary conversion which ends up being a little different from the actual quote. Thanks, Jim

To: esxtarus who wrote (1930)	4/9/1998 5:56:00 PM
From: Bernard Elbaum	Read Replies (1) \| Respond to of 8117

Can anyone familiar with the technology speak to the issue of patent protection and reverse engineering? Pyng believes they have excellent patent protection because they believe their patents give them proprietary rights to their mechanism for penetrating the sternal notch to the correct depth for different patients. What prospect is there for a potential competitor to reverse engineer and try to invent around this patent protection? I gather from Pyng that the sternal notch is a preferred point of entry.